FDA — authorised 1 September 1977
- Application: NDA017447
- Marketing authorisation holder: PFIZER
- Local brand name: NORPACE
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Norpace Cr in United States
FDA authorised Norpace Cr on 1 September 1977
Marketing authorisations
FDA
- Status: approved
Norpace Cr in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Norpace Cr approved in United States?
Yes. FDA authorised it on 1 September 1977; FDA has authorised it.
Who is the marketing authorisation holder for Norpace Cr in United States?
PFIZER holds the US marketing authorisation.